INTRODUCTION
Elevated plasma levels of enzymes normally found at high concentration in skeletal muscle are well described in patients with various muscle disorders (Pennington, 1980) and in patients with Duchenne muscular dystrophy the plasma levels of creatine kinase are often two orders of magnitude greater than normal. It is generally assumed that this release of intracellular constituents reflects a change in the permeability of the surface membrane of the muscle fibres in disease states, but elevated levels may also be found in normal subjects during or following particularly strenuous or unaccustomed exercise (Griffiths, 1966; Shumate et al., 1979) . Elevated levels of intramuscular calcium can cause damage to skeletal muscle (Duncan, 1978; Publicover et al., 1978) and increased intramuscular calcium levels have been implicated in the pathogenic mechanisms underlying muscular dystrophy (Bodenstein & Engel, 1978; Maunder-Sewry et al., 1980) . In addition, damage to isolated skeletal muscle following excessive contractile activity has been shown to be associated with an increase in total muscle calcium (Claremont et al., 1984) and is prevented by removal of external calcium from the incubation medium .
Various studies have been undertaken to try and elucidate the mechanism by which an increase in intracellular calcium induces damage to skeletal muscles (e.g. see Wrogmann & Pena, 1976; Ebashi & Sugita, 1979; Rodemann et al., 1981; Baracos et al., 1986) . Our previous inhibitor studies have suggested that elevated intracellular muscle calcium is deleterious to membrane integrity by activation of muscle phospholipase (probably phospholipase A2) leading to release of membrane-bound fatty acids and the formation of lysophospholipids. In addition, a possible role of free radical metabolites in the process of damage has been suggested by studies demonstrating that the vitamin E content of muscle influences the extent of enzyme efflux which occurs following a given amount of contractile activity . Further support for this hypothesis comes from e.s.r. studies in which an increase in the amount of stable free radical in muscle was found following damaging excessive contractile activity in vivo (Jackson et al., 1985a) .
One of the consequences of an activation of phospholipase A2 during damage would be a release of membrane-bound arachidonic acid, allowing its conversion to bioactive metabolites via cyclo-oxygenase or lipoxygenase enzymes. Since many of the products of these two enzyme systems are well known to have significant biochemical and physiological effects on cells, we have used inhibitors of these two enzyme systems to examine the possible roles ofarachidonic acid metabolites in enzyme effiux from experimentally damaged skeletal muscle in vitro.
MATERIALS AND METHODS
Female Wistar rats (100-200 g) maintained on a standard laboratory diet were killed by cervical dislocation and the soleus muscles were rapidly dissected and removed. The muscles were mounted in special holders and incubated in 3.0 ml of bicarbonate-buffered Ringer at 37 'C. The apparatus and conditions used were as previously described . After one or two initial 30 min incubation periods, the medium was exchanged and during the treatment period the agents known to damage the muscles and induce intracellular enzyme efflux were added to the medium. After 30 min the medium was exchanged and this was repeated every 30 min until the end of the experiment (a maximum of 90 min). The creatine kinase activity of the incubation media and muscles were analysed as previously described . 'the calcium content of incubated muscles was measured by atomic absorption spectrometry (Jackson et al., 1985b) The effect of two compounds capable of inhibiting both the cyclo-oxygenase-and lipoxygenase-catalysed conversion of arachidonic acid were tested. Muscles were treated with either calcium ionophore or DNP with and without either 100 /sM-phenidone (Fig. 3) or 400 ,sM-BW755C (Fig. 4) . Phenidone almost completely inhibited the efflux of creatine kinase from both calcium ionophore-and DNP-treated muscles (Fig. 3) , whereas BW755C appeared to permit the initial rise in creatine kinase efflux which occurred during calcium ionophore treatment, but prevented the further increase which occurred after removal of the ionophore (Fig. 4a) . BW755C significantly reduced the creatine kinase efflux from the DNP-treated muscles (Fig. 4b) .
Effect of NDGA on enzyme efflux from damaged muscles NDGA is a compound which has significant inhibitory effects on lipoxygenase activity and also has an ability to scavenge certain types of free radicals produced by non-enzymic systems. NDGA at a concentration of 5 #tM was found to have a significantly inhibitory effect on creatine kinase efflux from muscles treated with calcium ionophore (Fig. 5a ) and at 50 ,CM completely inhibited creatine kinase efflux from muscles treated with DNP (Fig. 5b) . (Figs. 1 and 2 ) which must result from release of arachidonic acid from its esterified storage form. This provides further support for our hypothesis that calcium is acting via activation of phospholipase to induce membrane changes leading to enzyme efflux .
A role for prostaglandin E2 in mediating calciuminduced protein degradation has been proposed by Rodemann et al. (1982) and release of prostaglandin F2a has been proposed to stimulate protein synthesis Smith et al., 1983) , but-prostaglandins do not appear to be involved in the process of enzyme efflux. Biphenylacetic acid is the active metabolite of the drug Lederfen and is an extremely efficient cyclooxygenase inhibitor (Sloboda & Osterberg, 1976) . In the present study it was found to decrease the non-stimulated 60 90 basal production of prostaglandin E2 and F2a by isolated muscles, and completely prevented the increased release of prostaglandins associated with treatment of the soleus muscles muscles with calcium ionophore or DNP (Figs. 1 and 2 ). DNP (b) in the However, biphenylacetic acid had no effect on the enzyme efflux following calcium ionophore or DNP ;roup and at treatment. oved from the The alternative enzyme system for conversion of in the treated arachidonic acid to active metabolites (i.e. lipoxygenase enzymes) has been described in several tissues and cell types, e.g. platelets (Nugteren, 1975) , pancreatic acinar cells (Rubin et al., 1982) , kidney glomeruli (Sraer et al., nuscle calcium 1983) , uterus (Morgan et al., 1984) and liver (Hewertson tment with and et al., 1984) , although not as far as we are aware in )GA (Table 1) (Higgs & Vane, 1983) and have also ving ionophore been found to prevent intracellular enzyme efflux from ie presence of the isolated skeletal muscle preparation (Figs. 3 and 4) . BW755C was however only found to inhibit the process a this study (i.e. at relatively high concentrations (i.e. > 350 tM) and it ie and NDGA) has been suggested that it may have an alternative action lid not inhibit as a weak calcium channel blocker at this concentration dition, the total (Higgs et al., 1985) . However, since extremely potent d with calcium calcium channel blockers, such as verapamil and Lgents was also nifedipine, are ineffective in reducing enzyme efflux from hore was found experimentally damaged skeletal muscle (Jones et al., muscle creatine 1984) this is unlikely to be the mode of action of BW755C nted for by the in this system. Further evidence for a protective effect luids.
due to the inhibition of lipoxygenase comes from studies using NDGA (Higgs & Vane, 1983) . At a concentration of 5 /tM this substance effectively prevented enzyme efflux induced by the calcium ionophore (Fig. 5a) (Halliwell & Gutteridge, 1985) but other substances having this property (propyl gallate or butylated hydroxytoluene) have previously been shown to have no protective effect in this system (Jackson & Edwards, 1986) . Table 1 demonstrates that the apparent protective effects of phenidone and NDGA are not via inhibition of calcium accumulation during muscle damage. It therefore seems likely that lipoxygenase products are involved in the process of calcium-induced enzyme efflux from skeletal muscle and furthermore the data presented here suggest that lipoxygenase enzymes are likely to be present in skeletal muscle, although the possibility that the effects seen are due to lipoxygenase in contaminating white cells cannot be completely discounted. BW755C has been shown to reduce the damage to cardiac muscle which occurs following experimental myocardial infarction (Mullane et al., 1984) . Those authors attributed the effect to inhibition of the toxic effects of invading leucocytes, but were nevertheless able to demonstrate lipoxygenase activity in control myocardium.
Removal of NDGA from the incubation fluid surrounding the skeletal muscle preparation following treatment with DNP caused a large and rapid efflux of creatine kinase (Fig. Sb) , demonstrating that the inhibition of lipoxygenase is readily reversible and that the phospholipase A-mediated release of arachidonic acid and other fatty acids alone is insufficient to induce enzyme efflux from skeletal muscle. This implies that a product or products of lipoxygenase activity must be capable of causing changes in muscle membrane permeability.
Several different forms of mammalian lipoxygenase have been described that catalyse the conversion of arachidonic acid to 5-HETE (Borgeat et al., 1976) , 12-HETE (Nugteren, 1975) and 15-HETE (Sraer et al., 1983) , but in other muscle tissues, i.e. smooth muscle and cardiac muscle, the 12-HETE lipoxygenase seems to predominate (Morgan et al., 1984; Mullane et al., 1984) . Vitamin E has recently been shown to inhibit lipoxygenase enzymes (Grossman & Waksman, 1984; Reddanna et al., 1985) , which may explain the reported protective effect of Vitamin E against skeletal muscle damage . There is some suggestion that the unstimulated basal efflux of creatine kinase from the incubated muscles may also occur by similar mechanisms to that seen with damage, since the creatine kinase activity during the first 30 min of incubation prior to administration of toxic agents was also found to be decreased by NDGA (Fig. 5a) or phenidone (Fig. 3a) .
In summary, the inhibitor studies reported here have suggested that lipoxygenase products are mediators of the intracellular enzyme efflux seen following experimental damage to skeletal muscle. Lack of suitable lipoxygenase inhibitors for use in man currently prevents studies to determine the relevance of this to intracellular enzyme efflux seen in patients with muscle diseases and in normal subjects following excessive exercise; studies to examine this aspect in animal models are required.
